Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

VBI Vaccines develops novel Zika virus vaccine candidate

July 21, 2016

First-in-human trial begins for GLS-5700 vaccine against Zika virus

July 20, 2016

Genetic variation in a lincRNA gene is associated with pneumococcal bacteremia

July 20, 2016

Merck KGaA initiates phase II trial in children with schistosomiasis

July 20, 2016

Novira Therapeutics reveals antiviral compounds to treat hepatitis B

July 20, 2016

FDA grants orphan drug designation to combination of antibodies against Ebola

July 20, 2016

Soligenix to present positive preliminary results of a heat stable Ebola vaccine formulation

July 19, 2016

Novira Therapeutics reports antiviral compounds

July 19, 2016

VLP Therapeutics wins award to develop malaria vaccine

July 18, 2016

Shionogi announces agreements on collaborative research

July 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...